Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know

04.12.24 23:50 Uhr

Werte in diesem Artikel
Aktien

508,80 EUR -9,90 EUR -1,91%

Indizes

PKT PKT

21.209,3 PKT -791,8 PKT -3,60%

19.392,7 PKT -716,4 PKT -3,56%

5.872,2 PKT -178,5 PKT -2,95%

Intuitive Surgical, Inc. (ISRG) closed at $549.80 in the latest trading session, marking a +1.49% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 0.61%. On the other hand, the Dow registered a gain of 0.69%, and the technology-centric Nasdaq increased by 1.31%.Heading into today, shares of the company had gained 5.15% over the past month, outpacing the Medical sector's loss of 1.45% and lagging the S&P 500's gain of 5.79% in that time.The investment community will be closely monitoring the performance of Intuitive Surgical, Inc. in its forthcoming earnings report. On that day, Intuitive Surgical, Inc. is projected to report earnings of $1.76 per share, which would represent year-over-year growth of 10%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.2 billion, up 14.32% from the year-ago period.For the annual period, the Zacks Consensus Estimates anticipate earnings of $6.88 per share and a revenue of $8.14 billion, signifying shifts of +20.49% and +14.3%, respectively, from the last year.It's also important for investors to be aware of any recent modifications to analyst estimates for Intuitive Surgical, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Intuitive Surgical, Inc. is currently a Zacks Rank #3 (Hold).Investors should also note Intuitive Surgical, Inc.'s current valuation metrics, including its Forward P/E ratio of 78.77. This valuation marks a premium compared to its industry's average Forward P/E of 28.85.It is also worth noting that ISRG currently has a PEG ratio of 4.22. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Instruments industry had an average PEG ratio of 2.47 as trading concluded yesterday.The Medical - Instruments industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 68, placing it within the top 28% of over 250 industries.The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Intuitive Surgical

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Intuitive Surgical Inc

Analysen zu Intuitive Surgical Inc

DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
26.01.2018Intuitive Surgical HoldCanaccord Adams
18.07.2017Intuitive Surgical Sector PerformRBC Capital Markets
30.06.2017Intuitive Surgical NeutralCantor Fitzgerald
30.05.2017Intuitive Surgical HoldCanaccord Adams
17.04.2017Intuitive Surgical Sector PerformRBC Capital Markets
DatumRatingAnalyst
23.01.2015Intuitive Surgical SellCRT Capital
22.10.2014Intuitive Surgical SellCRT Capital
09.01.2009Intuitive Surgical DowngradeBrean Murray, Carret & Co., LLC
26.08.2005Update Intuitive Surgical Inc. : UnderperformJefferies & Co

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"